CAPhO Endorsed Resources

As a national leader in oncology pharmacy, CAPhO supports high-quality educational initiatives that advance oncology pharmacy practice in Canada.

The resources listed below have successfully completed CAPhO’s endorsement review process and have been endorsed by CAPhO. Through this process, materials are reviewed for alignment with CAPhO’s mission and values, accuracy, currency, clarity, potential bias, and relevance to Canadian clinical practice.

CAPhO endorsement is valid for a period of two years, after which the material may be submitted for renewal.

For information about CAPhO’s endorsement process, eligibility requirements, fees, or to submit an initiative for consideration, please visit the CAPhO Endorsement Application Site.

CAPhO-Endorsed Resources

Clinical Resource: CDK4/6 Inhibitor Therapy in HR+, HER2– Breast Cancer